Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Methylprednisolone acetate topical preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
acétate de méthylprednisolone 40mg/mL, fiole de 3 mL de suspension injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone acetate 40mg/1mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone acetate 80mg/2mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone acetate [musculoskeletal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone acetate 40mg/mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone acetate 80mg/mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone acetate 40mg/mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone acetate 40mg suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone acetate 80mg/mL injection suspension 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone acetate 40mg/mL injection suspension 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylprednisolone acetate+lignocaine hydrochloride 80/20mg/2mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
acétate de méthylprednisolone et chlorhydrate de lidocaïne 40/10 mg/1 mL pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Methylprednisolone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely methylprednisolone acetate 120 milligram/3 milliliter conventional release suspension for injection vial |
Has precise active ingredient |
False |
Methylprednisolone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely methylprednisolone acetate 120 milligram/3 milliliter conventional release suspension for injection vial |
Has basis of strength substance (attribute) |
False |
Methylprednisolone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial |
Has basis of strength substance (attribute) |
False |
Methylprednisolone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial |
Has precise active ingredient |
False |
Methylprednisolone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial |
Has basis of strength substance (attribute) |
False |
Methylprednisolone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial |
Has precise active ingredient |
False |
Methylprednisolone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial |
Has precise active ingredient |
False |
Methylprednisolone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial |
Has basis of strength substance (attribute) |
False |
Methylprednisolone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial |
Has precise active ingredient |
False |
Methylprednisolone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial |
Has basis of strength substance (attribute) |
False |
Methylprednisolone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methylprednisolone acetate 40 mg/mL suspension for injection |
Has precise active ingredient |
True |
Methylprednisolone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Methylprednisolone acetate 40 mg/mL suspension for injection |
Has basis of strength substance (attribute) |
True |
Methylprednisolone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
Has precise active ingredient |
False |
Methylprednisolone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
Has basis of strength substance (attribute) |
False |
Methylprednisolone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
Has precise active ingredient |
True |
Methylprednisolone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Methylprednisolone acetate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |